Publications by authors named "N Kamoshita"

Epithelial cells, which are non-immune cells, not only function as a physical defence barrier but also continuously monitor and eliminate aberrant epithelial cells in their vicinity. In other words, it has become evident that epithelial cells possess immune cell-like functions. In fact, recent research has revealed that epithelial cells recognise the Major Histocompatibility Complex I (MHC-I) of aberrant cells as a mechanism for surveillance.

View Article and Find Full Text PDF
Article Synopsis
  • Genetic diagnosis is crucial for hemophilia patients, but some still have unidentified mutations; this study focused on a new approach using induced pluripotent stem cells (iPSCs) to investigate hemophilia A.
  • Researchers analyzed siblings with moderate hemophilia, found a deep intronic variant in the F8 gene that likely disrupts splicing, leading to abnormal mRNA and reduced factor VIII production.
  • The study successfully used genome editing to correct the splicing issue, restoring F8 mRNA and factor VIII production, demonstrating the potential of personalized gene therapy in treating hemophilia.
View Article and Find Full Text PDF
Article Synopsis
  • * Intravenous injection of AAV.GT5 resulted in similar liver transduction in both humanized mice and macaques, but it had a low recovery and short half-life due to its positive charge affecting blood interactions.
  • * Enhanced liver transduction was achieved by administering AAV.GT5 directly into the liver, and unlike AAV-Spark100, AAV.GT5 showed a lower tendency to generate neutralizing antibodies, suggesting it
View Article and Find Full Text PDF

Background: Base editing via CRISPR-Cas9 has garnered attention as a method for correcting disease-specific mutations without causing double-strand breaks, thereby avoiding large deletions and translocations in the host chromosome. However, its reliance on the protospacer adjacent motif (PAM) can limit its use. We aimed to restore a disease mutation in a patient with severe hemophilia B using base editing with SpCas9-NG, a modified Cas9 with the board PAM flexibility.

View Article and Find Full Text PDF